Use of adjuvanted trivalent influenza vaccine in older-age adults: a systematic review of economic evidence
Seasonal influenza is a very common disease. Yearly vaccination of at-risk population groups is a well-recognized cost-effective/cost-saving preventive measure. It is, however, unclear which available alternative has the most favorable economic profile. Some available options are: trivalent (TIV) an...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Taylor & Francis Group
2019-05-01
|
| Col·lecció: | Human Vaccines & Immunotherapeutics |
| Matèries: | |
| Accés en línia: | http://dx.doi.org/10.1080/21645515.2019.1578597 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|